World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

FORMULATION AND EVALUATION OF CEVIMELINE HYDROCHLORIDE ORALLY DISSOLVING FILM FOR SJOGRENS SYNDROME BY OPTIMAL DESIGN

Shubham R. Biyani*, Rajkumar S. Moon, Surendra G. Gattani and Sagar A. Kothawade

ABSTRACT

The aim of present study includes formulation and optimization of oral film loaded with cevimeline HCL by two factors and their three levels as optimal (custom) designs. The two viz. factor A (HPMC E15) and factor B (PEG 400) was selected on the basis of preliminary feasibility study. The percent drug dissolution in 10 minutes (R1), Disintegration time in sec (R2) and folding endurance (R3) were selected as dependent variables. Cevimeline hydrochloride is Para-sympathomimetic agent which stimulates muscarinic receptor (M3). It can significantly help to improve symptoms of dry mouth as well as increases salivary output in sjogrens syndrome. Orally dissolving film which produces local action in dry mouth condition, prevents first pass metabolism, and ultimately increase in systemic bioavailability. The oral film is formulated by solvent casting method using HPMC E15 as film forming agent, PEG 400 as plasticizer, tween 80 as surfactant, citric acid as saliva stimulating agent, sodium saccharin as sweetener and orange flavour etc. These films were evaluated for parameter like their appearance, weight variation, thickness, surface pH, folding endurance, percent elongation, percent moisture loss, drug content, In-vitro disintegration time and In-vitro dissolution study. The formulation F5 has more promising responses as per D-optimal design are % drug dissolution in 10 min about 99.90 %, average disintegration time about 23.66 second and folding endurance is 127. The formulation F5 was selected as optimised formulation.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR